DLIC1, but not DLIC2, is upregulated in colon cancer and this contributes to proliferative overgrowth and migratory characteristics of cancer cells.

MLA

Even, Ipek, et al. “DLIC1, but Not DLIC2, Is Upregulated in Colon Cancer and This Contributes to Proliferative Overgrowth and Migratory Characteristics of Cancer Cells.” The FEBS Journal, vol. 286, no. 4, Feb. 2019, pp. 803–20. EBSCOhost, https://doi.org/10.1111/febs.14755.

APA

Even, I., Reidenbach, S., Schlechter, T., Berns, N., Herold, R., Roth, W., Krunic, D., Riechmann, V., & Hofmann, I. (2019). DLIC1, but not DLIC2, is upregulated in colon cancer and this contributes to proliferative overgrowth and migratory characteristics of cancer cells. The FEBS Journal, 286(4), 803–820. https://doi.org/10.1111/febs.14755

Chicago

Even, Ipek, Sonja Reidenbach, Tanja Schlechter, Nicola Berns, Rosanna Herold, Wilfried Roth, Damir Krunic, Veit Riechmann, and Ilse Hofmann. 2019. “DLIC1, but Not DLIC2, Is Upregulated in Colon Cancer and This Contributes to Proliferative Overgrowth and Migratory Characteristics of Cancer Cells.” The FEBS Journal 286 (4): 803–20. doi:10.1111/febs.14755.